Michael P Porter1, John L Gore, Jonathan L Wright. 1. Division of Urology, VA Puget Sound Health Care System, Department of Urology, University of Washington, 1660 S. Columbian Way, S-112-GU, Seattle, WA 98108, USA. mporter@u.washington.edu
Abstract
BACKGROUND: Hospital cystectomy volume has been associated with in-hospital perioperative mortality in previous studies. In this study, we examine the relationship between hospital cystectomy volume and 90-day mortality in a population-based cohort of patients undergoing cystectomy for bladder cancer. METHODS: We performed a retrospective cohort study using population from the State of Washington Comprehensive Hospital Abstract Reporting System (CHARS) database. We examined the association between hospital cystectomy volume (categorized into volume tertiles) and cumulative 90-day mortality in patients undergoing cystectomy for bladder cancer. Multivariate regression was used to adjust for patient age, comorbid disease, year of surgery, and gender. Standard errors were clustered by discharge hospital. RESULTS: We identified 823 patients who underwent cystectomy for bladder cancer at 39 unique hospitals in 2003-2007. The unadjusted cumulative 90-day cumulative mortality was 5.4, 6.9, and 8.4% for patients discharged from hospitals in the high, medium, and low volume tertiles, respectively (P=0.35). In the multivariate analysis, the patients undergoing cystectomy who were discharged from hospitals in the highest volume tertile had a lower risk of death in the first 90 days postoperatively compared to patients discharged from hospitals in the low volume tertile, though the finding was not statistically significant (OR=0.68, 95% CI 0.29-1.56). CONCLUSIONS: Ninety-day cumulative mortality after cystectomy for bladder cancer is significant and may be associated with hospital cystectomy volume.
BACKGROUND: Hospital cystectomy volume has been associated with in-hospital perioperative mortality in previous studies. In this study, we examine the relationship between hospital cystectomy volume and 90-day mortality in a population-based cohort of patients undergoing cystectomy for bladder cancer. METHODS: We performed a retrospective cohort study using population from the State of Washington Comprehensive Hospital Abstract Reporting System (CHARS) database. We examined the association between hospital cystectomy volume (categorized into volume tertiles) and cumulative 90-day mortality in patients undergoing cystectomy for bladder cancer. Multivariate regression was used to adjust for patient age, comorbid disease, year of surgery, and gender. Standard errors were clustered by discharge hospital. RESULTS: We identified 823 patients who underwent cystectomy for bladder cancer at 39 unique hospitals in 2003-2007. The unadjusted cumulative 90-day cumulative mortality was 5.4, 6.9, and 8.4% for patients discharged from hospitals in the high, medium, and low volume tertiles, respectively (P=0.35). In the multivariate analysis, the patients undergoing cystectomy who were discharged from hospitals in the highest volume tertile had a lower risk of death in the first 90 days postoperatively compared to patients discharged from hospitals in the low volume tertile, though the finding was not statistically significant (OR=0.68, 95% CI 0.29-1.56). CONCLUSIONS: Ninety-day cumulative mortality after cystectomy for bladder cancer is significant and may be associated with hospital cystectomy volume.
Authors: John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg Journal: N Engl J Med Date: 2002-04-11 Impact factor: 91.245
Authors: Martin Nuttall; Jan van der Meulen; Nirree Phillips; Carlos Sharpin; David Gillatt; Gregor McIntosh; Mark Emberton Journal: J Urol Date: 2004-12 Impact factor: 7.450
Authors: Brent K Hollenbeck; Stephanie Daignault; Rodney L Dunn; Scott Gilbert; Alon Z Weizer; David C Miller Journal: J Urol Date: 2007-06 Impact factor: 7.450
Authors: Scott M Gilbert; Rodney L Dunn; David C Miller; Stephanie Daignault; Zaojun Ye; Brent K Hollenbeck Journal: Urology Date: 2008-04-18 Impact factor: 2.649
Authors: Linda S Elting; Curtis Pettaway; B Nebiyou Bekele; H Barton Grossman; Catherine Cooksley; Elenir B C Avritscher; Kamaldeen Saldin; Colin P N Dinney Journal: Cancer Date: 2005-09-01 Impact factor: 6.860
Authors: Christopher E Barbieri; Byron Lee; Michael S Cookson; John Bingham; Peter E Clark; Joseph A Smith; Sam S Chang Journal: J Urol Date: 2007-08-16 Impact factor: 7.450
Authors: Jinhai Huo; David R Lairson; Xianglin L Du; Wenyaw Chan; Jing Jiang; Thomas A Buchholz; B Ashleigh Guadagnolo Journal: Am J Clin Oncol Date: 2016-10 Impact factor: 2.339
Authors: Steffen Lebentrau; Thomas Enzmann; Mike Lehsnau; Frank Christoph; Martin Schostak; Matthias May Journal: World J Urol Date: 2018-08-09 Impact factor: 4.226
Authors: Harun Fajkovic; Joshua A Halpern; Eugene K Cha; Atessa Bahadori; Thomas F Chromecki; Pierre I Karakiewicz; Eckart Breinl; Axel S Merseburger; Shahrokh F Shariat Journal: World J Urol Date: 2011-06-09 Impact factor: 4.226
Authors: Matthew E Nielsen; Katherine Mallin; Mark A Weaver; Bryan Palis; Andrew Stewart; David P Winchester; Matthew I Milowsky Journal: BJU Int Date: 2014-05-22 Impact factor: 5.588
Authors: Jeffrey J Leow; Jens Bedke; Karim Chamie; Justin W Collins; Siamak Daneshmand; Petros Grivas; Axel Heidenreich; Edward M Messing; Trevor J Royce; Alexander I Sankin; Mark P Schoenberg; William U Shipley; Arnauld Villers; Jason A Efstathiou; Joaquim Bellmunt; Arnulf Stenzl Journal: World J Urol Date: 2019-01-25 Impact factor: 4.226